Category: Methodology

“People Don’t Like Open Plans”

(p. A1) Originally conceived in 1950s Germany, the open-plan office has migrated from tech start-ups to advertising agencies, architecture firms and even city governments. Now it has reached what is perhaps its most unlikely frontier yet: book publishing.
Few industries seem as uniquely ill suited to the concept. The process of acquiring, editing and publishing books is rife with moments requiring privacy and quiet concentration. There are the sensitive negotiations with agents; the wooing of prospective authors; the poring over of manuscripts.
. . .
(p. B6) Even as the walls of America’s workplaces continue to come crashing down, leaving only a handful of holdouts — like corporate law firms — a number of recent studies have been critical of the effects of open-plan offices on both the productivity and happiness of cube dwellers.
“The evidence against open-plan offices is mounting,” said Nikil Saval, the author of “Cubed: A Secret History of the Workplace.” “The idea is that these offices encourage collaboration and serendipitous encounters. But there’s not a lot of evidence behind these claims. Whereas there is a lot of evidence that people don’t like open plans.”
The notion of cookie-cutter cubicles is especially anathema to a certain breed of editors who see themselves more as men and women of letters than they do as businesspeople.
“It’s a world of words that we’re working towards, not an intellectual sweatshop,” said Jonathan Galassi, president and publisher of Farrar, Straus & Giroux and an opponent of open-plan offices.
For book editors, offices provide more than just privacy. They like to fill the bookcases inside with titles that they’ve published, making for a kind of literary trophy case to impress visitors.

For the full story, see:
JONATHAN MAHLER. “Cubicles Rise in a Brave New World of Publishing.” The New York Times (Mon., NOV. 10, 2014): A1 & B6.
(Note: ellipsis added.)
(Note: the online version of the story has the date NOV. 9, 2014, and has the title “Climate Tools Seek to Bend Nature’s Path.”)

The Saval book is:
Saval, Nikil. Cubed: A Secret History of the Workplace. New York: Doubleday, 2014.

“The World Is Not Only Stranger than We Imagine, It Is Stranger than We Can Imagine”

(p. 238) The British geneticist J. B. S. Haldane once commented, “The world is not only stranger than we imagine, it is stranger than we can imagine.” This famous quote is often used to support the notion that the mysteries of the universe are beyond our understanding. Here is another way to interpret his insight: Because so much is out there that is beyond our imagination, it is likely that we will discover new truths only when we accidentally stumble upon them. Development can then proceed apace.

Source:
Meyers, Morton A. Happy Accidents: Serendipity in Modern Medical Breakthroughs. New York: Arcade Publishing, 2007.
(Note: I have corrected a typo in the Haldane quote. Meyers mistakenly has “that” for the second “than.”)

Alertness to What Problem Can Be Solved with Unexpected Results

(p. 208) “Every scientist must occasionally turn around and ask not merely, ‘How can I solve this problem?’ but, ‘Now that I have come to a result, what problem have I solved?” This use of reverse questions is of tremendous value precisely at the deepest parts of science.”–NORBERT WIENER, INVENTION:THE CARE AND FEEDING OF IDEAS

Source:
Norbert Wiener as quoted in Meyers, Morton A. Happy Accidents: Serendipity in Modern Medical Breakthroughs. New York: Arcade Publishing, 2007.

Edison Claimed an Inventor Needs “a Logical Mind that Sees Analogies”

(p. C3) Thomas Edison famously said that genius requires “1% inspiration and 99% perspiration.” Edison’s third criterion for would-be innovators is less well-known but perhaps even more vital: “a logical mind that sees analogies.”
. . .
The art of analogy flows from creative re-categorization and the information that we extract from surprising sources. Take the invention of the moving assembly line. Credit for this breakthrough typically goes to Henry Ford, but it was actually the brainchild of a young Ford mechanic named Bill Klann. After watching butchers at a meatpacking plant disassemble carcasses moving past them along an overhead trolley, Klann thought that auto workers could assemble cars through a similar process by adding pieces to a chassis moving along rails.
Overcoming significant management skepticism, Klann and his cohorts built a moving assembly line. Within four months, Ford’s line had cut the time it took to build a Model T from 12 hours per vehicle to just 90 minutes. In short order, the moving assembly line revolutionized manufacturing and unlocked trillions of dollars in economic potential. And while in retrospect this innovation may seem like a simple, obvious step forward, it wasn’t; the underlying analogy between moving disassembly and moving assembly had eluded everyone until Klann grasped its potential.

For the full essay, see:
JOHN POLLACK. “Four Ways to Innovate through Analogies; Many of history’s most important breakthroughs were made by seeing analogies–for example, how a plane is like a bike.” The Wall Street Journal (Sat., Nov. 8, 2014): C3.
(Note: ellipsis added.)
(Note: the online version of the essay has the date Nov. 7, 2014, and has the title “Four Ways to Innovate through Analogies; Many of history’s most important breakthroughs were made by seeing analogies–for example, how a plane is like a bike.”)

The passages quoted above are related to Pollack’s book:
Pollack, John. Shortcut: How Analogies Reveal Connections, Spark Innovation, and Sell Our Greatest Ideas. New York, NY: Gotham Books, 2014.

Major Cancer Drugs Have Come from Unexpected Sources

(p. 182) Starting in the last decades of the twentieth century, last decades of the twentieth century, sophisticated genetics and molecular biology have been aimed toward a more precise understanding of the cell’s mechanisms. Yet, even here, chance has continued to be a big factor. Surprising discoveries led to uncovering cancer-inducing genes (oncogenes) and tumor-suppressing genes, both of which are normal cellular genes that, when mutated, can induce a biological effect that predisposes the cell to cancer development. A search for blood substitutes led to anti-angiogenesis drugs. Veterinary medicine led to oncogenes and vaccine preparations to tumor-suppressor genes. In one of the greatest serendipitous discoveries of (p. 183) modern medicine, stem cells were stumbled upon during research on radiation effects on the blood.
Experience has clearly shown that major cancer drugs have been discovered by independent, thoughtful, and self-motivated researchers–the cancer war’s “guerrillas,” to use the reigning metaphor–from unexpected sources: from chemical warfare (nitrogen mustard), nutritional research (methotrexate), medicinal folklore (the vinca alkaloids), bacteriologic research (cisplatin), biochemistry research (sex hormones), blood storage research (angiogenic inhibitors), clinical observations (COX-2 inhibitors), and embryology (thalidomide).

Source:
Meyers, Morton A. Happy Accidents: Serendipity in Modern Medical Breakthroughs. New York: Arcade Publishing, 2007.

Model Flaws Result in No Useful Climate Consensus

At the end of the first page of the commentary quoted below, the following biographical credentials were provided for the author of the commentary:

(p. C1) Dr. Koonin was undersecretary for science in the Energy Department during President Barack Obama’s first term and is currently director of the Center for Urban Science and Progress at New York University. His previous positions include professor of theoretical physics and provost at Caltech, as well as chief scientist of where his work focused on renewable and low-carbon energy technologies.

(p. C1) The idea that “Climate science is settled” runs through today’s popular and policy discussions. Unfortunately, that claim is misguided. It has not only distorted our public and policy debates on issues related to energy, greenhouse-gas emissions and the environment. But it also has inhibited the scientific and policy discussions that we need to have about our climate future.
. . .
(p. C2) We often hear that there is a “scientific consensus” about climate change. But as far as the computer models go, there isn’t a useful consensus at the level of detail relevant to assessing human influences.
. . .
• Although the Earth’s average surface temperature rose sharply by 0.9 degree Fahrenheit during the last quarter of the 20th century, it has increased much more slowly for the past 16 years, even as the human contribution to atmospheric carbon dioxide has risen by some 25%. This surprising fact demonstrates directly that natural influences and variability are powerful enough to counteract the present warming influence exerted by human activity.
Yet the models famously fail to capture this slowing in the temperature rise. Several dozen different explanations for this failure have been offered, with ocean variability most likely playing a major role. But the whole episode continues to highlight the limits of our modeling.
. . .
• A crucial measure of our knowledge of feedbacks is climate sensitivity–that is, the warming induced by a hypothetical doubling of carbon-dioxide concentration. Today’s best estimate of the sensitivity (between 2.7 degrees Fahrenheit and 8.1 degrees Fahrenheit) is no different, and no more certain, than it was 30 years ago. And this is despite an heroic research effort costing billions of dollars.
These and many other open questions are in fact described in the IPCC research reports, although a detailed and knowledgeable reading is sometimes required to discern them. They are not “minor” issues to be “cleaned up” by further research. Rather, they are deficiencies that erode confidence in the computer projections. Work to resolve these shortcomings in climate models should be among the top priorities for climate research.
Yet a public official reading only the IPCC’s “Summary for Policy Makers” would gain little sense of the extent or implications of these deficiencies. These are fundamental challenges to our understanding of human impacts on the climate, and they should not be dismissed with the mantra that “climate science is settled.”

For the full commentary, see:
STEVEN E. KOONIN. “Climate Science Is Not Settled.” The Wall Street Journal (Sat., Sept. 20, 2014): C1-C2.
(Note: italics in original; ellipses added.)
(Note: the online version of the commentary has the date Sept. 19, 2014.)

“Discovery Cannot Be Achieved by Directive”

(p. 170) As early as 1945 the medical advisory committee reporting to the committee reporting to the federal government on a postwar program for scientific research emphasized the frequently unexpected nature of discoveries:

Discoveries in medicine have often come from the most remote and unexpected fields of science in the past; and it is probable that this will be equally true in the future. It is not unlikely that significant progress in the treatment of cardiovascular disease, kidney disease, cancer, and other refractory conditions will be made, perhaps unexpectedly, as the result of fundamental discoveries in fields unrelated to these diseases…. Discovery cannot be achieved by directive. Further progress requires that the entire field of medicine and the underlying sciences of biochemistry, physiology, pharmacology, bacteriology, pathology, parasitology, etc., be developed impartially.

Their statement “discovery cannot be achieved by directive” would prove to be sadly prophetic.

Source:
Meyers, Morton A. Happy Accidents: Serendipity in Modern Medical Breakthroughs. New York: Arcade Publishing, 2007.
(Note: italics in original.)

“Folkman Persisted in His Genuinely Original Thinking”

(p. 141) As detailed by Robert Cooke in his 2001 book Dr. Folkman’s War, the successful answers to these basic questions took Folkman through diligent investigations punctuated by an astonishing series of chance observations and circumstances. Over decades, Folkman persisted in his genuinely original thinking. His concept was far in advance of technological and other scientific advances that would provide the methodology and basic knowledge essential to its proof, forcing him to await verification and to withstand ridicule, scorn, and vicious competition for grants. Looking back three decades later, Folkman would ruefully reflect: “I was too young to realize how much trouble was in store for a theory that could not be tested immediately.”

Source:
Meyers, Morton A. Happy Accidents: Serendipity in Modern Medical Breakthroughs. New York: Arcade Publishing, 2007.
(Note: italics in original.)

In Finding Cure for Ulcers, Marshall Was Not Constrained by the Need to Obtain Approval or Funding

(p. 113) Marshall was a youthful maverick, not bound by traditional theory and not professionally invested in a widely held set of beliefs. There is such a thing as being too much of an insider. Marshall viewed the problem with fresh eyes and was not constrained by the requirement to obtain approval or funding for his pursuits. It is also noteworthy that his work was accomplished not at a high-powered academic ivory tower with teams of investigators but instead far from the prestigious research centers in the Western Hemisphere.
The delay in acceptance of Marshall’s revolutionary hypothesis reflects the tenacity with which long-held concepts are maintained. Vested interests–intellectual, financial, commercial, status–keep these entrenched. Dogmatic believers find themselves under siege by a new set of explanations.

Source:
Meyers, Morton A. Happy Accidents: Serendipity in Modern Medical Breakthroughs. New York: Arcade Publishing, 2007.

Ideas Should Not Be Rejected Just Because They Disagree with Reigning Theory

(p. 107) . . . Claude Bernard, the nineteenth-century founder of experimental medicine, . . . famously said, “If an idea presents itself to us, we must not reject it simply because it does not agree with the logical deductions of a reigning theory.”

Source:
Meyers, Morton A. Happy Accidents: Serendipity in Modern Medical Breakthroughs. New York: Arcade Publishing, 2007.
(Note: ellipses added.)